Cellular and molecular determinants of cisplatin resistancePEREZ, R. P.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1535-1542, issn 0959-8049Conference Paper

Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcomaTAVIO, M; NASTI, G; SIMONELLI, C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1634-1637, issn 0959-8049Conference Paper

Pharmacogenetics and cancer chemotherapyIYER, L; RATAIN, M. J.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1493-1499, issn 0959-8049Conference Paper

The clinical development of paclitaxel and the paclitaxel/carboplatin combinationSCHWARTZ, G. N; PENDYALA, L; KINDLER, H et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1543-1548, issn 0959-8049Conference Paper

Attitudes of patients to randomised clinical trials of cancer therapyFALLOWFIELD, L. J; JENKINS, V; BRENNAN, C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1554-1559, issn 0959-8049Conference Paper

Oral fluoropyrimidines in the treatment of colorectal cancerMEROPOL, N. J.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1509-1513, issn 0959-8049Conference Paper

Autoregulation of 5-fluorouracil metabolismMCLEOD, H. L; SLUDDEN, J; HARDY, S. C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1623-1627, issn 0959-8049Conference Paper

Etoposide : Four decades of development of a topoisomerase II inhibitorHANDE, K. R.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1514-1521, issn 0959-8049Conference Paper

Expression of cyclin D1 and retinoblastoma protein in colorectal cancerPALMQVIST, R; STENLING, R; ÖBERG, A et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1575-1581, issn 0959-8049Conference Paper

Oral complications during treatment of malignant diseases in childhood : Effects of tooth brushingBONNAURE-MALLET, M; BUNETEL, L; TRICOT-DOLEUX, S et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1588-1591, issn 0959-8049Conference Paper

Long-term neuro-endocrine sequelae after treatment for childhood medulloblastomaHEIKENS, J; MICHIELS, E. M. C; BEHRENDT, H et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1592-1597, issn 0959-8049Conference Paper

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomasVAN DEN BENT, M. J; SCHELLENS, J. H. M; VECHT, C. J et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1570-1574, issn 0959-8049Conference Paper

Advance directives and other medical decisions concerning the end of life in cancer patients in JapanASAI, A; MIURA, Y; TANABE, N et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1582-1586, issn 0959-8049Conference Paper

Organised cervical cancer screening still leads to higher coverage than spontaneous screening in the NetherlandsBOS, A. B; VAN BALLEGOOIJEN, M; VAN GESSEL-DABEKAUSSEN, A. A. M. W et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1598-1601, issn 0959-8049Conference Paper

The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsBREISTØL, K; HENDRIKS, H. R; BERGER, D. P et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1602-1606, issn 0959-8049Conference Paper

A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomasGUNDERSEN, S; LOTE, K; WATNE, K et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1565-1569, issn 0959-8049Conference Paper